Literature DB >> 7857511

Inhibition of MAO by fractions and constituents of hypericum extract.

S Bladt1, H Wagner.   

Abstract

The inhibition of monoamine oxidase (MAO) by six fractions from hypericum extract and three characteristic constituents (as pure substances) were analyzed in vitro and ex vivo to study the antidepressive mechanism of action. Rat brain homogenates were used as the in vitro model, while the ex vivo analysis was performed after intraperitoneal application of the test substances to albino rats. Massive inhibition of MAO-A could be shown with the total extract and all fractions only at the concentration of 10(-3) mol/L. At 10(-4) mol/L, one fraction rich in flavonoides showed an inhibition of 39%, and all other fractions demonstrated less than 25% inhibition. Using pure hypericin as well as in all ex vivo experiments, no relevant inhibiting effects could be shown. From the results it can be concluded that the clinically proven antidepressive effect of hypericum extract cannot be explained in terms of MAO inhibition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7857511     DOI: 10.1177/089198879400700115

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  11 in total

1.  St John's wort as an antidepressant.

Authors:  P A De Smet; W A Nolen
Journal:  BMJ       Date:  1996-08-03

2.  Traditional Knowledge of Western Herbal Medicine and Complex Systems Science.

Authors:  Kathryn Niemeyer; Iris R Bell; Mary Koithan
Journal:  J Herb Med       Date:  2013-09       Impact factor: 3.032

3.  Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.

Authors:  Farida Larit; Khaled M Elokely; Narayan D Chaurasiya; Samira Benyahia; Manal A Nael; Francisco León; Mohammad Sanad Abu-Darwish; Thomas Efferth; Yan-Hong Wang; Djamila Belouahem-Abed; Samir Benayache; Babu L Tekwani; Stephen J Cutler
Journal:  Phytomedicine       Date:  2017-12-27       Impact factor: 5.340

Review 4.  Dietary inhibitors of monoamine oxidase A.

Authors:  Sarah E Dixon Clarke; Rona R Ramsay
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

Review 5.  Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca.

Authors:  Ilana Berlowitz; Klemens Egger; Paul Cumming
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.988

6.  Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets.

Authors:  Nicoletta Galeotti; Carla Ghelardini
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

7.  Hypericum perforatum L (St John's wort) preferentially increases extracellular dopamine levels in the rat prefrontal cortex.

Authors:  Takashi Yoshitake; Ryuji Iizuka; Shimako Yoshitake; Pia Weikop; Walter E Müller; Sven Ove Ogren; Jan Kehr
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 8.  Mechanism of action of St John's wort in depression : what is known?

Authors:  Veronika Butterweck
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  St. John's wort: role of active compounds for its mechanism of action and efficacy.

Authors:  Veronika Butterweck; Mathias Schmidt
Journal:  Wien Med Wochenschr       Date:  2007

10.  Effect of xanthone derivatives on animal models of depression.

Authors:  Xu Zhao; Qunying Chen; Yuan Liu; Chao Xia; Jincheng Shi; Maqing Zheng
Journal:  Curr Ther Res Clin Exp       Date:  2014-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.